Serological Predictors of Protection from Infection Upon Household Exposure to SARS‐CoV‐2
European Journal of Immunology · 2026
DOI: 10.1002/eji.70269 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2026. Verfasst von Henrike Maaß und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Viral Immunology, Helmholtz Center for Infection Research, Braunschweig, Germany. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Antibodies, Viral. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: research was funded by the Impulse and Networking fund of the Helmholtz Association through the grant, Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy-EXC 2155, IH was supported by the Hannover Biomedical Research School (HBRS) and the Center for Infection Biology (ZIB), Germany.
Abstract (Originalsprache)
Correlates of protection against symptomatic and severe breakthrough SARS‐CoV‐2 infections are well characterized. However, correlates of protection against virus transmission are poorly defined due to a lack of evidence in well‐designed prospective clinical trials. We studied a Croatian cohort of individuals with documented household exposure to SARS‐CoV‐2 in late 2022/early 2023. Sera were acquired at the time of the COVID‐19 diagnosis of the index case and before symptom onset of the test case. Samples were comprehensively analyzed for predictors of protection against virus transmission. PCR‐negative participants at day 0 were recalled 14 days later and re‐tested by PCR and IgM ELISA to identify any virus transmission, including asymptomatic ones. Out of nearly 200 tested serological parameters, several serological features differed between the participants that became PCR‐positive during the study period and those that remained PCR‐negative, although none remained significant after correction for multiple testing in the full cohort. Titers of variant‐specific neutralizing antibody showed the biggest difference and were higher in the uninfected subgroup. Since recent antigenic exposure may confound results, we identified the recipients exhibiting IgM seroconversion and censored them from the study. This refinement clearly separated infected and uninfected individuals by variant‐specific neutralization titers and IgA1 responses to BA4/5 RBD, which remained significant after correction. Therefore, our data indicate that high IgA1 and neutralizing titers may be predictive serum correlates of protection against SARS‐CoV‐2 transmission in intense contacts among household members, but only if variant‐specific antigen is used in serological assays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Viral Immunology, Helmholtz Center for Infection Research, Braunschweig, Germany.
- Centre For Individualised Infection Medicine (CiiM), a joint venture of Helmholtz Centre for Infection Research and Hannover Medical School, Hannover, Germany.
- Laboratory of Anti-Viral Antibody-Omics, TWINCORE-Institute for Experimental Infection Research, Helmholtz Center for Infection Research (HZI) and Medical School Hannover (MHH), Hannover, Germany.
- Emergency Department, Clinical Hospital Center Rijeka, Rijeka, Croatia.
- Department for Anesthesiology and Reanimatology, Emergency and Intensive Care Medicine, Medical Faculty Rijeka, Rijeka, Croatia.
- Department of Epidemiology, Helmholtz Center for Infection Research, Braunschweig, Germany.
Förderung
- research was funded by the Impulse and Networking fund of the Helmholtz Association through the grant
- Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy-EXC 2155
- IH was supported by the Hannover Biomedical Research School (HBRS) and the Center for Infection Biology (ZIB), Germany
- BL and MH received funding within the RESPINOW project from the Federal Ministry of Education and Research
Zitieren
APA
Maaß, H., Hinrichs, I., Pavletic, M., Harries, M., Prinke, T., Bdeir, N., Egelkamp, R., Lange, B., Bartsch, Y. C., Lerga, M., & Cicin-Sain, L. (2026). Serological Predictors of Protection from Infection Upon Household Exposure to SARS‐CoV‐2. European Journal of Immunology. https://doi.org/10.1002/eji.70269
Vancouver
Maaß H, Hinrichs I, Pavletic M, Harries M, Prinke T, Bdeir N, et al. Serological Predictors of Protection from Infection Upon Household Exposure to SARS‐CoV‐2. European Journal of Immunology. 2026. doi:10.1002/eji.70269
BibTeX
@article{Maa2026,
author = {Maaß, Henrike and Hinrichs, Imke and Pavletic, Martina and Harries, Manuela and Prinke, Tatjana and Bdeir, Najat and Egelkamp, Richard and Lange, Berit and Bartsch, Yannic C and Lerga, Mate and Cicin-Sain, Luka},
title = {Serological Predictors of Protection from Infection Upon Household Exposure to SARS‐CoV‐2},
journal = {European Journal of Immunology},
year = {2026},
doi = {10.1002/eji.70269}
}
EUVIMED